Two Sigma Advisers, LP’s Bristol-Myers Squibb Co Position
Does Two Sigma Advisers, LP own Bristol-Myers Squibb Co (BMY)? Not currently — the last reported position was 8.27M shares worth $446M in Q4 2025; the fund’s latest 13F (Q1 2026) no longer reports it.
Position Value
$446M
Q4 2025
Shares
8.27M
% of Portfolio
+0.87%
Quarters Held
29
position exited
Position History BMY
Reported value by quarter
| Quarter | Shares | Value | % of Portfolio |
|---|---|---|---|
| Q4 2025 | 8.27M | $446M | +0.87% |
| Q3 2025 | 4.72M | $213M | +0.43% |
| Q2 2025 | 1.12M | $52M | +0.11% |
| Q1 2025 | 738.5K | $45M | +0.10% |
| Q4 2024 | 1.86M | $105M | +0.24% |
| Q3 2024 | 9.55M | $494M | +1.16% |
| Q2 2024 | 11.35M | $472M | +1.05% |
| Q1 2024 | 8.94M | $485M | +1.12% |
| Q4 2023 | 8.90M | $457M | +1.07% |
| Q3 2023 | 6.62M | $384M | +0.98% |
| Q2 2023 | 1.87M | $120M | +0.31% |
| Q1 2023 | 396.3K | $27M | +0.07% |
| Q4 2022 | 405.8K | $29M | +0.08% |
| Q3 2022 | 3.05M | $217M | +0.63% |
| Q2 2022 | 4.71M | $363M | +1.03% |
| Q1 2022 | 4.36M | $318M | +0.85% |
| Q4 2021 | 6.62M | $413M | +1.03% |
| Q3 2021 | 6.60M | $391M | +1.01% |
| Q2 2021 | 815.7K | $55M | +0.14% |
| Q1 2021 | 19.3K | $1M | 0.00% |
| Q4 2020 | 1.29M | $80M | +0.21% |
| Q3 2020 | 5.23M | $315M | +0.90% |
| Q2 2020 | 3.77M | $222M | +0.64% |
| Q1 2020 | 1.18M | $66M | +0.25% |
| Q4 2019 | 6.50M | $417M | +0.97% |
| Q3 2019 | 8.67M | $440M | +1.08% |
| Q2 2019 | 8.59M | $389M | +0.97% |
| Q1 2019 | 8.06M | $385M | +0.97% |
| Q4 2018 | 2.78M | $145M | +0.40% |
Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Two Sigma Advisers, LP’s full portfolio or all institutional holders of BMY.